Clinical Trials Adults with Acute Myelogenous Leukemia: Experience of the Eastern Cooperative Oncology Group-Reference-Cited by-同舟云学术

Clinical Trials Adults with Acute Myelogenous Leukemia: Experience of the Eastern Cooperative Oncology Group

Published:1994 Issue: Volume: Page:541-546
ISSN:0440-0607
Container-title:Haematology and Blood Transfusion / Hämatologie und Bluttransfusion
language:
Short-container-title:

Author:

Rowe J. M.,Andersen J. W.,Cassileth P. A.,Oken M. M.,Bennett J. M.,Wiernik P. H.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-78350-0_96.pdf

Reference7 articles.

1. Preisler H, Davis RB, Kirschner J et al. (1987) Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute myelomonocytic leukemia: A Cancer and Leukemia Group B Study. Blood 69: 1441–1446

2. Mayer RJ (1987) Current chemotherapeutic approaches in the management of previously untreated adults with de novo acute myelogenous leukemia. Semin Hematol 14: 384–397

3. Cassileth PA, Harrington DP, Hines JD et al. (1988) Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia. J Clin Oncol 6(4): 583–587

4. Bennett JM, Begg CB (1981) Acute myeloid leukemia by correlation of subtypes with response and survival. Cac Res 41: 4833–4837

5. Cassileth PA, Begg CB, Bennett JM et al. (1984) A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia. Blood 63: 843–847

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor;British Journal of Haematology;2009-02

2. Drug therapy for acute myeloid leukemia;Blood;2005-08-15

3. The efficacy of diphtheria-growth factor fusion proteins is enhanced by co-administration of cytosine arabinoside in an immunodeficient mouse model of human acute myeloid leukemia;Leukemia Research;2004-11

4. Efficacy and safety of imatinib in adult patients with c-kit–positive acute myeloid leukemia;Blood;2004-05-15

5. Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials;Leukemia;2003-07-29